Cargando…
Patient preferences and priorities for haemophilia gene therapy in the US: A discrete choice experiment
INTRODUCTION: Gene therapy has shown promise in clinical trials for patients with haemophilia, but patient preference studies have focused on factor replacement treatments. AIM: We conducted a discrete choice experiment (DCE) to investigate the relative importance and differential preferences patien...
Autores principales: | Witkop, Michelle, Morgan, George, O'Hara, Jamie, Recht, Michael, Buckner, Tyler W., Nugent, Diane, Curtis, Randall, O'Mahony, Brian, Skinner, Mark W., Mulhern, Brendan, Cawson, Matthew, Ali, Talaha M., Sawyer, Eileen K., Li, Nanxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290457/ https://www.ncbi.nlm.nih.gov/pubmed/34310811 http://dx.doi.org/10.1111/hae.14383 |
Ejemplares similares
-
Evidence of a disability paradox in patient‐reported outcomes in haemophilia
por: O’Hara, Jamie, et al.
Publicado: (2021) -
Association of factor expression levels with annual bleeding rate in people with haemophilia B
por: Burke, Tom, et al.
Publicado: (2022) -
Achieving the unimaginable: Health equity in haemophilia
por: Skinner, Mark W., et al.
Publicado: (2019) -
Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in Europe
por: Burke, Tom, et al.
Publicado: (2021) -
How to discuss gene therapy for haemophilia? A patient and physician perspective
por: Miesbach, Wolfgang, et al.
Publicado: (2019)